Clinical Trial Update: Double Dose 4-AP on Functional Recovery After Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating a double-dose regimen of 4-aminopyridine for functional recovery after spinal cord injury, currently recruiting in Phase 1 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• 4-aminopyridine (4-aminopyridine)

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: SCI - Spinal Cord Injury | Phase 1, Phase 2 | Status: RECRUITING